Substituent activity relationship studies on new azolo benzoxazepinyl oxazolidinones

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 23, 2006, Pages 8032-8042

  Das, Jagattaran ^a   Sitaram Kumar, M ^a   Subrahmanyam, D ^a   Sastry, T V R S ^a   Prasad Narasimhulu, C ^a   Laxman Rao, C V ^a   Kannan, M ^a   Roshaiah, M ^a   Awasthi, Riti ^a   Patil, Santosh N ^a   Sarnaik, H M ^a   Rao Mamidi, N V S ^a   Selvakumar, N ^a   Iqbal, Javed ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Antibacterial; Linezolid; Oxazolidinones; Tricyclic

Indexed keywords

2 BROMO N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]ACETAMIDE; 2 CHLORO N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]ACETAMIDE; 3,3,3 TRIFLUORO N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]PROPIONAMIDE; [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]CYCLOPROPRANAMIDE; BENZYL [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]CARBAMATE; ETHYL [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]CARBAMATE; LINEZOLID; METHYL [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]CARBAMATE; N [2 OXO 3 (2,3,3A,4 TETRAHYDRO 1H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL)OXAZOLIDIN 5 YLMETHYL]ACETAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]ACETAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]ACRYLAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]BENZAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]ISOVALERYLAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]PROPIONAMIDE; N [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]THIOACETAMIDE; O ETHYL [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]THIOCARBAMATE; O METHYL [3 (4H,6H 5 OXA 10B AZABENZ[E]AZULEN 8 YL) 2 OXOOXAZOLIDIN 5 YLMETHYL]THIOCARBAMATE; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG SCREENING; DRUG SENSITIVITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BENZAZEPINES; MOLECULAR MIMICRY; OXAZOLIDINONES; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750065139     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.040     Document Type: Article

References (8)

1. Lin A.H., Murray R.W., Vidmar T.J., and Marotti K.R. Antimicrob. Agents Chemother. 41 (1997) 2127-2131
2. Shinabarger D.L., Marotti K.R., Murray R.W., Lin A.H., Melchior E.P., Swaney S.M., Dunyak D.S., Demyan W.F., and Buysee J.M. Antimicrob. Agents Chemother. 41 (1997) 2132-2136
3. Swaney S.M., Aoki H., Ganoza M.C., and Shinabarger D.L. Antimicrob. Agents Chemother. 42 (1998) 3251-3255
4. Mutnick A.H., Enne V., and Jones R.N. Ann. Pharmacother. 37 (2003) 769-774
5. Hutchinson D.K. Expert Opin. Ther. Patents 14 (2004) 1309-1328
6. Selvakumar N., Srinivas D., Khera M.K., Sitaram Kumar M., Rao Mamidi N.V.S., Sarnaik H., Chandrasekhar C., Rao B.S., Raheem M.A., Das J., Iqbal J., and Rajagopalan R. J. Med. Chem. 45 (2002) 3953-3962
7. While this manuscript preparation was in progress, the following letter appeared. Griera R., Cantos-Llopart C., Amat M., Bosch J., Castillo J.C.D., and Huguet J. Bioorg. Med. Chem. Lett. 15 (2005) 2515-2517
8. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standards. M7-A5. National Committee for Clinical Laboratory Standards: Wayne, PA, 2000.